Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial

被引：0
|
作者：
Nils Venhoff
Wolfgang A. Schmidt
Peter Lamprecht
Hans-Peter Tony
Christine App
Christian Sieder
Carolin Legeler
Claudia Jentzsch
Jens Thiel
机构：
[1] Klinik für Rheumatologie und Klinische Immunologie,Department Innere Medizin
[2] Vaskulitiszentrum Freiburg,Department of Immunology, Hepatology & Dermatology
[3] Universitätsklinikum Freiburg,undefined
[4] Immanuel Krankenhaus Berlin,undefined
[5] Klinik für Innere Medizin,undefined
[6] Abteilung Rheumatologie und Klinische Immunologie in Berlin-Buch,undefined
[7] Universität zu Lübeck,undefined
[8] Klinik für Rheumatologie und klinische Immunologie,undefined
[9] Medizinische Klinik II,undefined
[10] Universitätsklinik,undefined
[11] Rheumatology/Immunology,undefined
[12] Novartis Pharma GmbH,undefined
[13] Novartis Pharma AG,undefined
来源：
Trials | / 22卷
关键词：
Giant cell arteritis; Secukinumab; Phase II trial; Placebo; Double-blind;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Efficacy and Safety of Tocilizumab in Patients with Refractory Takayasu Arteritis: Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial in Japan
    Nakaoka, Yoshikazu
    Isobe, Mitsuaki
    Takei, Syuji
    Tanaka, Yoshiya
    Ishii, Tomonori
    Yokota, Shumpei
    Nomura, Akira
    Yoshida, Seitaro
    Nishimoto, Norihiro
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [42] Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
    Camm, A. John
    Toft, Egon
    Torp-Pedersen, Christian
    Vijayaraman, Pugazhendhi
    Juul-Moller, Steen
    Ip, John
    Beatch, Gregory N.
    Dickinson, Garth
    Wyse, D. George
    EUROPACE, 2012, 14 (06): : 804 - 809
  • [43] Safety and efficacy of clonazepam in patients with hemifacial spasm: A double-blind, randomized, placebo-controlled trial
    Seol-Hee, Baek
    Je-Young, Shin
    Sung-Yeon, Sohn
    Kee, Hong Park
    Jun-Soon, Kim
    Bongjae, Kim
    So, Hyun Ahn
    Kyomin, Choi
    Yoon-Ho, Hong
    Sung, Jung-Joon
    PARKINSONISM & RELATED DISORDERS, 2022, 103 : 1 - 6
  • [44] A PHASE 2, RANDOMIZED, DOUBLE- BLIND PLACEBO-CONTROLLED STUDY TO TEST THE EFFICACY AND SAFETY OF MAVRILIMUMAB IN GIANT CELL ARTERITIS: STUDY DESIGN AND METHODOLOGY
    Pupim, Lara
    Unizony, Sebastian
    Cid, Maria
    Pilipski, Lucas
    Gandhi, Rohan
    Pirrello, Joe
    Ren, Ai
    Fang, Fang
    Martin, Dana
    Paolini, John
    RHEUMATOLOGY, 2019, 58
  • [45] Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study
    Hide, Michihiro
    Yagami, Akiko
    Togawa, Michinori
    Saito, Akihiro
    Furue, Masutaka
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (02) : 317 - 325
  • [46] Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase-II Trial: AdrenoMedullin for Ischemic Stroke Study
    Yoshimoto, Takeshi
    Saito, Satoshi
    Omae, Katsuhiro
    Hattori, Yorito
    Fukuma, Kazuki
    Kitamura, Kazuo
    Kakuta, Ryosuke
    Kita, Toshihiro
    Maruyama, Hirofumi
    Yamamoto, Haruko
    Ihara, Masafumi
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (06):
  • [47] Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial
    McDonald, C.
    Wu, S.
    Gulati, S.
    Komaki, H.
    Ruiz-Garcia, M.
    Kostera-Pruszczyk, A.
    Vlodavets, D.
    Chae, J.
    Jong, Y.
    Karachunski, P.
    Statland, J.
    Lorentzos, M.
    Penematsa, V
    Chou, C.
    Lin, M.
    Werner, C.
    Trifillis, P.
    Gordon, G.
    Klein, M.
    NEUROMUSCULAR DISORDERS, 2022, 32
  • [48] Efficacy and safety of the Qiguiyin formula in severe pneumonia: study protocol for a randomized, double-blind, placebo-controlled clinical trial
    Huang Po
    Guo Yuhong
    Zhao Jingxia
    Li Bo
    Wu Yanqing
    Liu Qingquan
    Journal of Traditional Chinese Medicine, 2020, 40 (02) : 317 - 323
  • [49] The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
    Zhongwei Sha
    Yiping Hou
    Chunchun Xue
    Ou Li
    Zhimin Li
    Huiru Wang
    Wenjing Zhang
    Jian Xu
    Trials, 21
  • [50] The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
    Sha, Zhongwei
    Hou, Yiping
    Xue, Chunchun
    Li, Ou
    Li, Zhimin
    Wang, Huiru
    Zhang, Wenjing
    Xu, Jian
    TRIALS, 2020, 21 (01)
12345